tradingkey.logo
tradingkey.logo
Search

FDA Grants Orphan Drug Designation To Biostar Pharma's Utidelone

ReutersSep 25, 2025 3:28 PM
facebooktwitterlinkedin
View all comments0

- Biostar Pharma Inc:

  • THE FDA GRANTED ORPHAN DRUG DESIGNATION TO BIOSTAR PHARMA'S UTIDELONE FOR THE TREATMENT OF PANCREATIC CANCER

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

0/500
Commenting Guidelines
Loading...

Recommended Articles

Tradingkey
KeyAI